Skip to main content

Table 3 Cell viability of crude extracts on RBL-2H3 cells

From: In vitro anti-allergic activity of Moringa oleifera Lam. extracts and their isolated compounds

 7.81 μg/mL15.63
μg/mL
31.25
μg/mL
M. oleifera leaves100.37 ± 1.61101.65 ± 4.4592.79 ± 6.50
M. oleifera seed96.52 ± 5.50103.22 ± 2.9095.07 ± 1.77
M. oleifera pod93.32 ± 13.1795.72 ± 10.0192.30 ± 5.18
Ethyl-(E)–undec-6-enoate (MOLH 1)94.29 ± 3.7390.78 ± 7.3684.30 ± 9.38
Quercetin (MOLE 1)93.96 ± 6.9582.15 ± 19.9585.66 ± 17.00
Kaempferol (MOLE 2)108.82 ± 3.69100.06 ± 9.25100.18 ± 7.82
3,5,6-trihydroxy-2-(2,3,4,5,6-pentahydroxyphenyl)-4H-chromen-4-one (MOLE 3)95.36 ± 5.5586.50 ± 3.6883.15 ± 6.98
β-sitosterol-3-O-glucoside (MOLA 1)69.54 ± 6.7464.39 ± 6.2962.60 ± 11.26
Stigmasterol (MOPE 1)68.78 ± 2.3254.39 ± 7.1558.32 ± 5.99
Oleic acid (MOSE 1)82.03 ± 3.2466.95 ± 4.3363.63 ± 3.45
Glucomoringin (MOSA 1)77.87 ± 35.8875.29 ± 10.2458.63 ± 24.19
Ketotifen fumarate (positive control)112.74 ± 22.95100.81 ± 17.0088.00 ± 3.13